Celiac Disease: What You Should Know as a Provider
Once you're logged in, please click the "ENTER" button to your right. Your attendance will then be confirmed.
Once you register for the course, you will have 30 days (approximately 1 month) from the date of enrollment to complete the course. The exact date that your access expires will be indicated within the Course Summary box on this webpage.
Experts in celiac disease agree the #1 barrier to its diagnosis is providers failing to recognize its clinical picture and consider it in their differential diagnosis. According to Fasano et al (2003), this could be because they believe it is a rare disease and/or it only manifests as diarrhea in children.
Rubio-Tapia et al (2012) demonstrated the prevalence of celiac disease in the United States is 0.71%, or 1 in 141. An earlier study by Fasano et al (2003) showed the prevalence is 0.75%, or 1 in 133 in the not-at-risk population of the United States. Therefore, it is not a rare disease. Additionally, Rubio et al (2012) concluded the vast majority of cases (83%) are not diagnosed.
This educational activity is designed to increase provider awareness of celiac disease and to give you the tools necessary to suspect, diagnose, and possibly even manage a patient with celiac disease. My aim is to increase your scope of understanding of celiac disease.
- Define celiac disease.
- Identify the epidemiology of celiac disease (who, when, and where).
- Review the pathogenesis of celiac disease.
- Recognize the varying clinical presentations of celiac disease (classical and non-classical).
- Recognize how to diagnose someone with celiac disease, as well as the role of screening.
- Treat a patient who has been diagnosed with celiac disease.
- Treat the serious complications of celiac disease.
- List conditions that are linked to celiac disease.
Matt Hill, PA-S
Des Moines University
Relevant to the content of this educational activity, Mr. Hill has no financial relationships with commercial interest companies to disclose.
Copyright: All rights reserved. By viewing this activity, participants agree to abide by copyright and trademark laws, intellectual property rights, and all other applicable laws of the United States of America. No part of the syllabus may be used or reproduced in any manner whatsoever without written permission, except in the case of brief quotations embodied in articles or reviews.
Internet CME Policy: The Office of Continuing Medical Education (CME) at Des Moines University (DMU) is committed to protecting the privacy of its customers. DMU CME maintains its Internet site as an information resource and service for health professionals. DMU CME will keep your personal and credit information confidential when you participate in an Internet based program. Your information will never be given to anyone outside of the DMU CME program. DMU CME collects only the information necessary to provide you with the services that you request.
Continuing Education Credit
- MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS). Des Moines University (DMU) is accredited by the IMS to provide continuing medical education for physicians. DMU designates this enduring materials activity for 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 1.0 AOA Category 2-B credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
- Nurse: Des Moines University is Iowa Board of Nursing approved provider #112. This live activity has been reviewed and approved for 1.0 continuing education contact hour(s). No partial credit awarded.
- Other healthcare providers: This live activity is designated for 1.0 AMA PRA Category 1 Credit(s)™.
No commercial interest company provided financial support for this continuing education activity.
Everyone in a position to control the content of this educational activity will disclose to the CME provider and to attendees all relevant financial relationships with any commercial interest. They will also disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content and the selection of speakers is the responsibility of the activity director. Firms providing financial support did not have input in these areas. The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.
- 1.00 AOA Category 2B
- 1.00 AMA PRA Category 1 Credits™
- 1.00 IBON
- 1.00 CE Contact Hour(s)